methane and cyclin d1

methane has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdelrahim, M; Morrow, D; Phillips, T; Porter, W; Qin, C; Safe, S; Samudio, I; Smith, R; Spencer, K; Stewart, J1

Other Studies

1 other study(ies) available for methane and cyclin d1

ArticleYear
A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:3

    Topics: 3T3-L1 Cells; Adipocytes; Animals; Apoptosis; Breast Neoplasms; Carcinogens; Cell Cycle; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Separation; Cloning, Molecular; Cyclin D1; Dose-Response Relationship, Drug; Down-Regulation; Estrogen Receptor alpha; Female; Flow Cytometry; G1 Phase; Humans; Indoles; Ligands; Luciferases; Methane; Mice; Plasmids; Prostaglandin D2; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Resting Phase, Cell Cycle; Structure-Activity Relationship; Transcription Factors; Transcriptional Activation; Transfection; Two-Hybrid System Techniques

2004